Apollo Hospitals Enterprise share news, announcements and annual reports
NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap
Apollo Hospitals Enterprise Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1983 on BSE, Jan 1996 on NSE
Last close ₹8,448.00up ₹248.00 (3.02%)BSE ₹8,400.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹8,200.00.
30 Oct: open ₹8,195.00, high ₹8,448.00, low ₹8,176.00
52-week range of traded prices to 30 Oct 2026
₹6,696.50Low, 23 Jan 2026₹9,070.50High, 23 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,21,469 Cr97th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 58.13
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 12.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 23.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,72,15658.2% delivered
Apollo Hospitals Enterprise orders, deals and press releases
70 filed, newest first. Page 2 of 2.
Dec 2016
Jun 2016
Mar 2016
12 Mar · Business
Jan 2016
Jun 2015
Jan 2015
Sep 2014
Jan 2013
Dec 2012
Jul 2012
Jun 2012
Dec 2011
12 Dec · Business
Pursuant to the approval of members at the Extraordinary General Meeting held on May 29, 2010, the Company had issued and allotted 1,544,621 share warrants to Dr. Prathap C. Reddy, one of the promoters of the Company on June 12, 2010, with each warrant convertible into one equity share of the Company of nominal value of Rs. 10/- each at a price of Rs. 771.76 which Includes premium of Rs. 761.76 per share calculated in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009. The said warrants were convertible into equity shares within a period of 18 months from the date of allotment of warrants i.e., on or before December 11, 2011. The Company obtained the members approval for effecting a stock split in the face value of the equity shares from Rs. 10/- each to Rs. 5/- each, The stock split was effected from September 03, 2010 onwards. Pursuant to the terms of the Issue, 1,544,621 warrants allotted to Dr. Prathap C. Reddy and the corresponding issue price of Rs. 771.76 stood adjusted accordingly as 3,089,242 warrants of face value of Rs. 5/- each at a price of Rs. 385.88 including premium of Rs. 380.88 per share. Further, the Company has Informed that the Share Allotment Committee met on December 10, 2011 and approved the allotment of 3,089,242 equity shares of face value of Rs. 5/- each at a price of Rs. 385.88 per share to Dr. Prathap C. Reddy, promoter of the Company. Further, the Company note that consequent to the above allotment, the paid up share capital of the Company has been increased to Rs. 672,333,090/- (consisting of 134,466,618 equity shares of Rs. 5/- each) from Rs. 656,886,880/- (consisting of 131,377,376 equity shares of Rs. 5/- each).
Jul 2011
Feb 2011
7 Feb · Business
Committee of Board of Directors at its meeting held on February 05, 2011 approved the allotment of 3,276,922 Warrants convertible into equity shares to Dr. Prathap C Reddy, with each warrant convertible into one equity share of the Company of nominal value of Rs.5/- each at a price of Rs.472.46 which includes a premium of Rs.467.46 per share. The warrants shall be convertible into equity shares at any time within 18 months from the date of allotment.
Dec 2010
Jun 2010
14 Jun · Business
Committee of Board of Directors at its meeting held on June 12, 2010 approved the allotment of 1,544,621 Warrants convertible into equity shares to Dr. Prathap C Reddy, with each warrant convertible into one equity share of the Company of nominal value of Rs.10/- each at a price of Rs.771.76 which includes a premium of Rs.761.75 per share. The warrants shall be convertible into equity shares at any time within 18 months from the date of allotment.
Aug 2007
1 Aug · Business
Apollo Hospitals Enterprise Limited (AHEL) have been in negotiation with British American Investment Co (Mauritius) Ltd (BAI) for associating in a Joint Venture for setting up a multi speciality hospital on a state land provided by Government of Mauritius. The Joint Venture Company, British American Hospitals Enterprise Limited (BAHEL) has been formed and Joint Venture Agreement between AHEL, BAI, BAI Medical Centres Limited (BMCL), subsidiary of BAI and the said BAHEL, has been entered into on 31st July 2007 in this regard. AHEL will be holding 26% of the total equity capital of Joint Venture Company and the balance 74% will be held by BMCL
Jan 2007
25 Jan · Business
Company had informed the Exchange regarding authorizing Dr. Prathap C Reddy, Chairman to sign the Shareholders/ Joint Venture Agreement with One Equity Partner LLC (OEP), a private equity investment company, incorporated under the laws of Delaware, USA for setting up of hospital at Mumbai. The Company now informs the Exchange that "Shareholders Agreement among Apollo Hospitals Enterprise Limited (AHEL), Eleanor Holdings, Mauritius (a Company promoted by One Equity Partners) and Western Hospitals Corporation Pvt Limited (WHCPL) was signed on 24th January 2007. Dr. Prathap C Reddy, Chairman of Apollo Hospitals Group signed the agreement on behalf of AHEL. The Joint Venture Company (WHCPL) will set up healthcare facilities at Mumbai".